A case report: Cerebrospinal Fluid Diversion in Idiopathic Intracranial Hypertension after COVID-19 Infection
Keywords:
Idiopathic intracranial hypertension, increased intracranial pressure, cerebrospinal fluid diversion, venous sinus thrombosis, COVID-19Abstract
Idiopathic intracranial hypertension or Pseudotumor cerebri is a disorder related to high pressure within the skull caused by abnormal absorption or production of cerebrospinal fluid. Patients usually present with symptoms of headache and blur vision and physical examination shows papilledema and sixth nerve palsy. There are some case reports about COVID-19 and idiopathic intracranial hypertension, COVID-19 can cause systemic inflammation lead to hypercoagulable state and cause venous thrombosis. Venous thrombosis obstructs brain parenchymal drainage and cause high pressure within brain parenchyma. For diagnosis criteria of idiopathic intracranial hypertension, lumbar puncture is performed. If intracranial pressure is greater than 250 cmH2O and normal CSF profile was acquired, the idiopathic intracranial hypertension is diagnosed. Treatment in idiopathic intracranial hypertension start with life style modification and medical treatment. Surgical treatment such as CSF diversion is selected for patient who failed conservative treatment of rapidly progress in symptoms. The treatment of this idiopathic intracranial hypertension patient with COVID-19 is similar to the other patients.
Downloads
References
WHO Coronavirus (COVID-19) Dashboard,2023[cited 2023 Feb 20]. Available from: https://covid19.who.int/
Wakerley BR, Mollan SP, Sinclair AJ. Idiopathic intracranial hypertension: Update on diagnosis and management. Clin Med (Lond). 2020;20(4):384-8.
Dandy WE: Intracranial pressure without brain tumor. Ann Surg. 1937;106:492-513.
Galgano MA, Deshaies EM: An update on the management of pseudotumor cerebri. Clin Neurol Neurosurg. 2013; 115:252–9.
Giridharan N, Patel SK, Ojugbeli A, Nouri A, Shirani P, Grossman AW, et al. Understanding the complex pathophysiology of idiopathic intracranial hypertension and the evolving role of venous sinus stenting: a comprehensive review of the literature. Neurosurg Focus. 2018;45(1):E10.
Mukharesh L, Bouffard MA, Fortin E, Brann DH, Datta SR, Prasad S, et al. Pseudotumor Cerebri Syndrome with COVID-19: A Case Series. J Neuroophthalmol. 2022 Sep 1;42(3): e545-e547. doi: 10.1097/WNO.0000000000001467. Epub 2022 Apr 27. PMID: 35482432.
Thakur S, Mahajan M, Azad RK, Thakur JS. COVID-19 Associated Idiopathic Intracranial Hypertension and Acute Vision loss. Indian J Otolaryngol Head Neck Surg. 2022 Dec; 10:1-4. https://doi. org/10.1007/s12070-022-03303-x.
Jack S, Kannappan H990 Rapidly progressing idiopathic intracranial hypertension after a COVID-19 infection. Archives of Disease in Childhood. 2022;107: A118-A119.
Rajabi MT, Rafizadeh SM, Aghajani AH, Pirzadeh M. Idiopathic intracranial hypertension as a neurological manifestation of COVID-19: A case report. J Fr Ophtalmol. 2022 Sep;45(7): e303-e305. doi: 10.1016/j.jfo.2022.02.019. Epub 2022 May 18. PMID: 35659426; PMCID: PMC9152708.
Markey KA, Mollan SP, Jensen RH, Sinclair AJ: Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol. 2016; 15:78–91.
Dinkin MJ, Patsalides A: Venous sinus stenting for idiopathic intracranial hypertension: where are we now? Neurol Clin. 2017; 35:59–81.
Elder BD, Goodwin CR, Kosztowski TA, Radvany MG, Gailloud P, Moghekar A, et al: Venous sinus stenting is a valuable treatment for fulminant idiopathic intracranial hypertension. J Clin Neurosci. 2015; 22:685–9.
McGeeney BE, Friedman DI: Pseudotumor cerebri pathophysiology. Headache. 2014; 54:445–8.
Mollan SP, Hornby C, Mitchell J, Sinclair AJ. Evaluation and management of adult idiopathic intracranial hypertension. Pract Neurol. 2018;18(6):485-8.
Sinclair A J, Burdon M A, Nightingale P G, Ball A K, Good P, Matthews T D et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study BMJ 2010; 341: c2701 doi:10.1136/bmj.c2701.
Menger RP, Connor DE, Jr., Thakur JD, Sonig A, Smith E, Guthikonda B, et al. A comparison of lumboperitoneal and ventriculoperitoneal shunting for idiopathic intracranial hypertension: an analysis of economic impact and complications using the Nationwide Inpatient Sample. Neurosurg Focus. 2014;37(5):E4.
Azad TD, Zhang Y, Varshneya K, Veeravagu A, Ratliff JK, Li G. Lumboperitoneal and Ventriculoperitoneal Shunting for Idiopathic Intracranial Hypertension Demonstrate Comparable Failure and Complication Rates. Neurosurgery. 2020 Feb 1;86(2):272-80. doi: 10.1093/neuros/nyz080. PMID: 30937428.
de Oliveira AJM, Pinto FCG, Teixeira MJ. Comparative Study of the Effectiveness of Lumboperitoneal and Ventriculoperitoneal Shunting with Neuronavigation in the Treatment of Idiopathic Intracranial Hypertension. Neurol India. 2020 Sep-Oct;68(5):1061-4. doi: 10.4103/0028-3886.294549. PMID: 33109853.
Karsy M, Abou-Al-Shaar H, Bowers CA, Schmidt RH. Treatment of idiopathic intracranial hypertension via stereotactic placement of biventriculoperitoneal shunts. J Neurosurg. 2018;130(1):136-44.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles in this journal are copyrighted by the x may be read and used for academic purposes, such as teaching, research, or citation, with proper credit given to the author and the journal.use or modification of the articles is prohibited without permission.
statements expressed in the articles are solely the opinions of the authors.
authors are fully responsible for the content and accuracy of their articles.
other reuse or republication requires permission from the journal."
